Witnessing the stock’s movement on the chart, on Thursday, CERo Therapeutics Holdings Inc (NASDAQ: CERO) had a quiet start as it plunged -94.69% to $0.1, before settling in for the price of $1.79 at the close. Taking a more long-term approach, CERO posted a 52-week range of $1.72-$895.40.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 96.81%. This publicly-traded company’s shares outstanding now amounts to $1.19 million, simultaneously with a float of $1.14 million. The organization now has a market capitalization sitting at $0.11 million. At the time of writing, stock’s 50-day Moving Average stood at $4.8437, while the 200-day Moving Average is $14.9982.
CERo Therapeutics Holdings Inc (CERO) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. CERo Therapeutics Holdings Inc’s current insider ownership accounts for 5.48%, in contrast to 18.61% institutional ownership. According to the most recent insider trade that took place on Dec 13 ’24, this organization’s 10% Owner sold 2,998,908 shares at the rate of 0.06, making the entire transaction reach 179,934 in total value, affecting insider ownership by 13,005,169. Preceding that transaction, on Dec 12 ’24, Company’s 10% Owner sold 1,614,541 for 0.07, making the whole transaction’s value amount to 113,018. This particular insider is now the holder of 16,004,077 in total.
CERo Therapeutics Holdings Inc (CERO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.7 per share during the current fiscal year.
CERo Therapeutics Holdings Inc’s EPS increase for this current 12-month fiscal period is 96.81% and is forecasted to reach -2.71 in the upcoming year.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) Trading Performance Indicators
Let’s observe the current performance indicators for CERo Therapeutics Holdings Inc (CERO). It’s Quick Ratio in the last reported quarter now stands at 0.56.
In the same vein, CERO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -258.19, a figure that is expected to reach -1.08 in the next quarter, and analysts are predicting that it will be -2.71 at the market close of one year from today.
Technical Analysis of CERo Therapeutics Holdings Inc (CERO)
Going through the that latest performance of [CERo Therapeutics Holdings Inc, CERO]. Its last 5-days volume of 23.37 million indicated improvement to the volume of 1.0 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 5.52% While, its Average True Range was 8.09.
Raw Stochastic average of CERo Therapeutics Holdings Inc (CERO) in the period of the previous 100 days is set at 0.04%, which indicates a major fall in contrast to 0.28% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.2943 that was lower than 0.7564 volatility it exhibited in the past 100-days period.
